Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 September 2019 | Story Cornelius Hagenmeier (Director: UFS International Office)

The management of the University of the Free State (UFS) is deeply concerned about the xenophobic and afrophobic attacks presently occurring in our country. Xenophobia is the ‘fear and hatred of strangers or foreigners or of anything that is strange or foreign’ (Merriam-Webster Dictionary), whereas afrophobia can be understood as the ‘fear and hatred of the cultures and people of Africa’.

The UFS strongly condemns all forms of xenophobic and afrophobic actions and thought and expresses its solidarity with the members of the University community hailing from other regions of the African continent and the world. The UFS is committed to promoting diversity, social justice, inclusivity, and transformation. Its University community is united in its diversity. The UFS cherishes diversity as a catalyst for positive change, innovative research, and cutting-edge teaching and learning. Xenophobic actions, threats or statements will never be tolerated at the UFS. The UFS is committed to nurturing and entrenching a human-rights culture and advocating human rights both within the context of the University and beyond.

Xenophobia, afrophobia and discrimination jeopardise the process of internationalisation at the University. They limit the international and multicultural exposure of our students, which are important to achieve graduate attributes and specifically to develop students’ international and intercultural competence. The UFS is strategically strengthening its collaborations and partnerships in Africa and beyond. It recognises the positive force of diversifying the knowledge paradigms with which it interacts. International staff members, postdoctoral fellows, and students make a significant contribution to the academic project, scholarship traditions, and intellectual diversity of the University. The management of the UFS will do all in its power to ensure the wellbeing of all members of its international University community.



Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: + 27 51 401 2584 | +27 51 401 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393


News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept